ASO Author Reflections: The Role of Beta-Blockers in Gastric Cancer—A Pathway to Personalized Therapy?
addition of BB to pembrolizumab-based immunotherapy in patients with unresectable GC.Further interventional studies are needed to assess the role of BB in localized GC, particularly in combination with standard treatments and to better understand its potential synergy with immunotherapy.
Authors
- Fritz Brinkmann (ORCID: https://orcid.org/0000-0002-6663-0940)
- Nerma Crnovrsanin (ORCID: https://orcid.org/0009-0006-0036-9897)
- Georg Martin Haag (ORCID: https://orcid.org/0000-0002-9410-9968)
- Henrik Nienhüser (ORCID: https://orcid.org/0000-0002-0475-9538)
- Sabine Schiefer (ORCID: https://orcid.org/0000-0001-9430-8994)
- Ingmar F. Rompen (ORCID: https://orcid.org/0000-0002-0257-1654)
- Thomas Schmidt (ORCID: https://orcid.org/0000-0002-2772-8160)
- Thomas Longerich (ORCID: https://orcid.org/0000-0001-8888-1030)
- Leila Sisic (ORCID: https://orcid.org/0000-0003-1260-5771)
- Sebastian Zimmer (ORCID: https://orcid.org/0000-0002-1531-2088)
- Wenjun Hu (ORCID: https://orcid.org/0000-0001-8563-8844)
- Johanna Arnscheidt (ORCID: https://orcid.org/0000-0001-7277-2200)
- Mohammed Al‐Saeedi (ORCID: https://orcid.org/0000-0002-0583-4472)
- Sarah Zumsande
Institutions
- Heidelberg University (DE)
- University Hospital Heidelberg (DE)
- National Center for Tumor Diseases (DE)
- University Hospital Cologne (DE)
Publication Details
- Journal
- Annals of Surgical Oncology
- Published
- 2025-04-24
- DOI
- https://doi.org/10.1245/s10434-025-17326-5
- Primary Topic
- Cancer, Stress, Anesthesia, and Immune Response
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Heidelberger Stiftung Chirurgie
- Universitätsklinikum Heidelberg